SmPC labeling artefact for Raredimab in Switzerland. Version 5.9. Language: de.

Artifact ID
LBL-009
Type
SmPC
Product
Market
Switzerland
Version
5.9
Language
de
Status
In Progress
Last Reviewed
2023-10-11
Included Statements (3)
IDTypeSourceTextApproved
STMT-025SafetySmPC Section 4.5Fertility studies in animals have not shown any adverse effects on fertility.…2023-05-21
STMT-026ContraindicationSmPC Section 4.8Serious hypersensitivity reactions, including anaphylaxis, have been reported.…2023-06-16
STMT-027DosingSmPC Section 4.5The pharmacokinetic profile is linear over the therapeutic dose range of 5–200 m…2023-04-05
Change History
2022-08-22 · Nadia Petrova
Posology revision